BioTelemetry (BEAT) Tops Q4 EPS by 4c

BioTelemetry (NASDAQ: BEAT) reported Q4 EPS of $0.04, $0.04 better than the analyst estimate of $0.00. Revenue for the quarter came in at $37.2 million versus the consensus estimate of $38.4 million.

For earnings history and earnings-related data on BioTelemetry (BEAT) click here.

You May Also Be Interested In

• Ennis (EBF) Reports In-Line Q1 EPS
• AeroVironment restates quarterly financials, citing $89M goodwill error
• Playboy to buy back 16.6M shares from Fortress at $1.05 each